Abstract:Background and purpose Parkinson disease (PD) is a complex and heterogeneous neurodegenerative disorder with a broad spectrum of clinical manifestations, determined by a complex interplay of environmental and genetic factors. This study aimed to investigate genetic variants associated with PD and assess their impact on the disease phenotype through genotype–phenotype correlations. Methods We employed a targeted resequencing panel to analyze 27 genes linked to PD in a cohort of 1185 PD patients from southern Spain. Variants were categorized based on the American College of Medical Genetics and Genomics pathogenicity criteria. Demographic and clinical data were also collected. Results Among the patients analyzed, 13.5% carried potential disease‐causing pathogenic or likely pathogenic variants in 12 different genes, indicating significant genetic heterogeneity. The most frequently affected genes were LRRK2, PRKN, and GBA1 (accounting for 72.1% of positive cases). Sex‐specific differences were observed, with a higher proportion of female patients carrying LRRK2 variants. Differences in age at onset and clinical features were also observed among the different mutated genes. Notably, variants in genes associated with atypical parkinsonism presented distinct clinical presentations, highlighting the importance of genetic factors in the differential diagnosis. Conclusions Our study provides valuable information on the genetic landscape of PD and its clinical manifestations. The observed genotype–phenotype correlations, along with sex‐specific differences, emphasize the complexity of PD pathogenesis, underlining the importance of personalized approaches to PD diagnosis and treatment. Further investigations into genetic interactions and population‐specific effects are warranted to enhance our understanding of PD etiology and improve patient care.

Una Mutación En El Gen PARK2 Causa Enfermedad De Parkinson Juvenil En Una Extensa Familia Colombiana

Mutation C.255dela in the Park2 Gene As Cause of Juvenile Parkinson'S Disease in A Large Colombian Family

Novel Compound Heterozygous of PARKIN Causes Early-Onset Parkinson's Disease

A Genetic Cluster of Early Onset Parkinson's Disease in a Colombian Population

Cognitive Alterations in Juvenile Parkinson´s Disease Caused by the C212Y Mutation in the Parkin Gene.

[Genetic Study of a Parkinson's Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene].

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

Mutation Analysis of Genes Associated with Autosomal Recessive in Early-Onset Parkinsonism

A Novel Homozygous SYNJ1 Mutation in Two Siblings with Typical Parkinson's Disease.

Analysis of a Patient with Early-Onset Parkinson's Disease and PARK7 Gene Variation

Parkinson's Disease Gene Screening in Familial Cases from Central and South America

Identification of SYNJ1 in a Complex Case of Juvenile Parkinsonism Using a Multiomics Approach

Mutation of PARK2 Gene in Sporadic Early-Onset Parkinson's Disease and Its Clinical Characteristics

Understanding Parkinson disease in Spain: Genetic and clinical insights

Novel compound heterozygous of PARKIN causes early-onset Parkinson’s disease

Análisis De Ligamiento Genético Del Síndrome De Gilles De La Tourette En Una Familia Colombiana

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Establishment of induced pluripotent stem cell lines derived from Parkinson’s disease Mexican patients: A sporadic (UNAMi002-A) and a familial (UNAMi003-A) case carrying a mutation in PINK1

Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism

Transcriptome datasets of neural progenitors and neurons differentiated from induced pluripotent stem cells of healthy donors and Parkinson's disease patients with mutations in the PARK2 gene

PINK1 P.k520rfsx3 Mutation Identified in a Chinese Family with Early-Onset Parkinson’s Disease